Get the Stockscreener App
8.72
12.27%
-1.22
Electrocore Inc stock is traded at $8.72, with a volume of 136.36K.
It is down -12.27% in the last 24 hours and up +24.75% over the past month.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
See More
Previous Close:
$9.94
Open:
$9.9
24h Volume:
136.36K
Relative Volume:
1.44
Market Cap:
$72.34M
Revenue:
$32.03M
Net Income/Loss:
$-13.97M
P/E Ratio:
-5.1631
EPS:
-1.6889
Net Cash Flow:
$-8.25M
1W Performance:
-10.66%
1M Performance:
+24.75%
6M Performance:
+80.91%
1Y Performance:
+62.69%
1-Day Range:
$8.55
$9.99
1-Week Range:
$8.55
$10.37
52-Week Range:
$4.16
$10.37
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Compare ECOR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
8.72 | 82.46M | 32.03M | -13.97M | -8.25M | -1.6889 |
ABT
Abbott Laboratories
|
91.07 | 158.12B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.66 | 115.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
81.67 | 105.19B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
48.55 | 72.61B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.96 | 50.35B | 6.30B | 1.07B | 1.09B | 1.8406 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
electroCore, Inc. Hits New 52-Week High of $10.27, Reflecting Strong Growth - Markets Mojo
electroCore, Inc. Hits New 52-Week High of $10.35, Reflecting Strong Growth - Markets Mojo
electroCore, Inc. Hits New 52-Week High of $9.18, Surpassing Previous Milestones - Markets Mojo
electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub - Yahoo Finance
electroCore Inc. (ECOR) Q1 2026 Earnings: EPS Surges Past Estimates by 40.76%Long-Term Guidance - The Legal Advocate
electroCore Inc. (ECOR) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Investor Sentiment - The Legal Advocate
Electrocore CFO and interim president Lev sells $60,003 of company stock By Investing.com - Investing.com South Africa
electroCore Inc. (ECOR) Gains Ground: Bullish Move Toward ResistancePSAR Stop - The Legal Advocate
Electrocore CFO and interim president Lev sells $60,003 of company stock - Investing.com Nigeria
electroCore (ECOR) CFO sells 6,667 shares in open-market trade - Stock Titan
ElectroCore Inc. (ECOR) Surges 3.9% as Stock Approaches Key Resistance LevelOBV Breakout - The Legal Advocate
electroCore, Inc. Hits New 52-Week High of $9.64, Reflecting Strong Growth - Markets Mojo
electroCore (ECOR) insider sale: 3,000 shares for $19,500 reported - Stock Titan
ECOR (NASDAQ: ECOR) files Form 144 notice reporting proposed insider sales - Stock Titan
Electrocore director Thomas J. Errico buys $59,852 in stock By Investing.com - Investing.com Nigeria
electroCore Stock (ECOR) Opinions on Recent Surge and Clinical Validation - Quiver Quantitative
ElectroCore (ECOR) Surges 33% as Trading Volume Spikes – Key Levels in FocusDescending Triangle - The Legal Advocate
Electrocore director Thomas J. Errico buys $59,852 in stock - Investing.com
electroCore (ECOR) director boosts stake with 9,992-share open-market buy - Stock Titan
electroCore Inc. (ECOR) Q1 2026 Earnings: EPS Surprise Drives Stock RallyDividend Growth Analysis - The Legal Advocate
ElectroCore touts 30% growth outlook, VA opportunity at LD Micro Conference - MSN
ElectroCore CFO sells $19,500 in shares - Investing.com India
ElectroCore CFO sells $19,500 in shares By Investing.com - Investing.com India
electroCore (ECOR) CFO sells 3,000 shares to cover RSU taxes - Stock Titan
electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference - Yahoo Finance
Relay Therapeutics (RLAY) surges 16.4%: Is this an indication of further gains? - MSN
ECOR: Rapid growth, unique vagus nerve tech, and new partnerships drive future expansion - TradingView
electroCore (ECOR) Stock: Down -2.49%, Support Test at $5.96 2026-05-17Dealer Delta - Newser
ElectroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026 - marketscreener.com
electroCore (ECOR) Drops -5.29% — Key Support at $5.79 2026-05-15Imbalance Zone - Newser
electroCore (ECOR) Q1 2026 Earnings Transcript - AOL.com
Vagus Nerve Stimulators Market to Reach USD 1.86 Billion by 2033 - openPR.com
ECOR (NASDAQ) brokered sale notice: 45,000 shares valued $291,600 - Stock Titan
Quell device shows pain reduction in fibromyalgia study By Investing.com - Investing.com India
electroCore (ECOR) Reports Positive Fibromyalgia Trial Results - GuruFocus
Quell device shows pain reduction in fibromyalgia study - Investing.com
electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia - The Manila Times
electroCore Announces Publication in JAMA Highlighting the - GlobeNewswire
Q2 Earnings Forecast for electroCore Issued By HC Wainwright - MarketBeat
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):